United Therapeutics reported $89.9M in Stock for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Baxter International BAX:US $ 2065M 48M
Bayer BAYN:GR € 10125M 332M
Biogen BIIB:US $ 1347.9M 93.1M
Biomarin Pharmaceutical BMRN:US $ 710.98M 2.95M
Emergent Biosolutions EBS:US $ 386.4M 20.1M
Esperion Therapeutics ESPR:US $ 23.71M 3.68M
Gilead Sciences GILD:US $ 2988M 8M
GlaxoSmithKline GSK:LN 6330M 114M
Halozyme Therapeutics HALO:US $ 58.55M 0.21M
IONIS PHARMACEUT IONS:US $ 24.1M 1.9M
Omeros OMER:US $ 978K 213K
Ptc Therapeutics PTCT:US $ 16.44M 0.21M
Regeneron Pharmaceuticals REGN:US $ 1983.9M 318.6M
Teva Pharmaceutical TEVA:IT 4.36B 44M
United Therapeutics UTHR:US $ 89.9M 2.3M
Vertex Pharmaceuticals VRTX:US $ 321.62M 22.76M